Theophylline/ephedra/hydroxyzine

Theophylline/ephedra/hydroxyzine
Combination of
Theophylline	Stimulant
Ephedra (medicine)	Stimulant
Hydroxyzine	Antihistamine
Clinical data
Trade names	Marax
AHFS/Drugs.com	Micromedex Detailed Consumer Information
Routes of; administration	By mouth
ATC code	R03DA74 (WHO) ;
Identifiers
CAS Number	64095-02-9;
PubChem SID	135272520;

Theophylline/ephedra/hydroxyzine (trade name Marax) is a drug that was used for the treatment of asthma. It was a combination of theophylline, ephedra,^[1] and hydroxyzine, and taken by mouth.^[2]^[3] It is no longer manufactured in the US due to approval of ephedra being withdrawn by the FDA.^{[citation needed]}

References

^ Hunt TM (2011). Drug Games: The International Olympic Committee and the Politics of Doping, 1960–2008. University of Texas Press. p. 45. ISBN 978-0-292-73957-4. Retrieved 20 July 2018.
^ Marax Micromedex Detailed Consumer Information. Accessed 23 April 2021.
^ Fixley M, Shen DD, Azarnoff DL (June 1977). "Theophylline bioavailability: a comparison of the oral absorption of a theophylline elixir and two combination theophylline tablets to intravenous aminophylline". The American Review of Respiratory Disease. 115 (6): 955–62. doi:10.1164/arrd.1977.115.6.955 (inactive 1 November 2024). PMID 262107.{{cite journal}}: CS1 maint: DOI inactive as of November 2024 (link)

This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.

[1] Hunt TM (2011). Drug Games: The International Olympic Committee and the Politics of Doping, 1960–2008. University of Texas Press. p. 45. ISBN 978-0-292-73957-4. Retrieved 20 July 2018.

[2] Marax Micromedex Detailed Consumer Information. Accessed 23 April 2021.

[3] Fixley M, Shen DD, Azarnoff DL (June 1977). "Theophylline bioavailability: a comparison of the oral absorption of a theophylline elixir and two combination theophylline tablets to intravenous aminophylline". The American Review of Respiratory Disease. 115 (6): 955–62. doi:10.1164/arrd.1977.115.6.955 (inactive 1 November 2024). PMID 262107.{{cite journal}}: CS1 maint: DOI inactive as of November 2024 (link)

[1]

[2]

[3]

See also

References